Phase I studies establish feasibility, tolerability of oral delivery of heparin Oct. 26, 1998 No Comments
First high-affinity, nonpeptide BB1, BB2 receptor antagonists designed at Parke-Davis Oct. 26, 1998 No Comments
Clinical trial results reported, development plans outlined for Aastrom stem cell therapy system Oct. 20, 1998 No Comments
ThromboSol effectively preserves platelet function and cell recovery in in vivo study Oct. 8, 1998 No Comments
RSS